Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative dexmedetomidine nasal spray for recovery and sleep after gynecologic laparoscopic total hysterectomy
ChiCTR2500103050Phase 4Not yet recruiting
- Sponsor
- The First College of Clinical Medical Science, China Three Gorges University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Dexmedetomidine hydrochloride nasal spray group with Placebo group (2 arms). Primary endpoint: Quality of recovery 1 day after surgery. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2500103050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103050.